| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2009 | US20090042868 Indoleamine 2,3-Dioxygenase (IDO) Inhibitors |
| 02/12/2009 | US20090042867 Compounds for the treatment of alzheimer's disease |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042865 Dna-pk inhibitors |
| 02/12/2009 | US20090042864 Pyrazole compounds |
| 02/12/2009 | US20090042863 Therapeutic Agent for Diabetes |
| 02/12/2009 | US20090042862 Novel compounds |
| 02/12/2009 | US20090042861 Prophylactic or Therapeutic Agent for Depression or Anxiety Disorder |
| 02/12/2009 | US20090042860 Compounds for the Treatment of Hepatitis C |
| 02/12/2009 | US20090042858 Lactam containing hcv inhibitors |
| 02/12/2009 | US20090042857 Novel Pharmaceutical |
| 02/12/2009 | US20090042856 Pyridazinone derivatives used for the treatment of pain |
| 02/12/2009 | US20090042855 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042853 of sulopenem, comprising 2-ethoxy-2-methyl-1-oxopropoxy)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, used to treat and prevent bacterial infection in humans; antibiotics |
| 02/12/2009 | US20090042852 Novel Pyridine Compounds |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042850 Compositions and methods for cytoprotection |
| 02/12/2009 | US20090042849 Phosphorylation of 5-lipoxygenase at ser523 and uses thereof |
| 02/12/2009 | US20090042848 Copper complexes |
| 02/12/2009 | US20090042847 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| 02/12/2009 | US20090042845 Suppression and prevention of tumors |
| 02/12/2009 | US20090042844 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 02/12/2009 | US20090042843 Inhalation Device Containing Plural Doses of a Pharmaceutical Composition |
| 02/12/2009 | US20090042842 Analogues of cilostazol |
| 02/12/2009 | US20090042841 Novel heterocyclic derivatives as m-glu5 antagonists |
| 02/12/2009 | US20090042840 Phospholipids for Use in the Treatment of an Allergic Inflammatory Condition |
| 02/12/2009 | US20090042839 Crystalline forms of ibandronate sodium |
| 02/12/2009 | US20090042838 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin |
| 02/12/2009 | US20090042837 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/12/2009 | US20090042836 Proteasome inhibitors |
| 02/12/2009 | US20090042835 Compositions and methods for ameliorating hyperlipidemia |
| 02/12/2009 | US20090042834 Stabilized Glycosaminoglycan Preparations and Related Methods |
| 02/12/2009 | US20090042833 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 02/12/2009 | US20090042832 Novel salts of boswellic acids and selectively enriched boswellic acids and processes for the same |
| 02/12/2009 | US20090042831 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 02/12/2009 | US20090042830 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 02/12/2009 | US20090042829 Nucleic Acid-Lipopolymer Compositions |
| 02/12/2009 | US20090042828 Nucleic acid with 1st sequence encoding antisense RNAi specific for targeting regions of copper zinc superoxide dismutase that cause inherited amyotrophic lateral sclerosis, and a 2nd sequence encoding a RNAi resistant replacement gene with silent mutations encoding messenger RNA resistant to cleavage |
| 02/12/2009 | US20090042827 Antiviral oligonucleotides targeting hbv |
| 02/12/2009 | US20090042826 Use of the AXL receptor for diagnosis and treatment of renal disease |
| 02/12/2009 | US20090042825 Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer |
| 02/12/2009 | US20090042824 Methods and Kits for Linking Polymorphic Sequences to Expanded Repeat Mutations |
| 02/12/2009 | US20090042823 Uses of broad spectrum rnai therapeutics against influenza |
| 02/12/2009 | US20090042822 Method to enhance delivery of glutathione and atp levels in cells |
| 02/12/2009 | US20090042821 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| 02/12/2009 | US20090042820 Tubulin Binding Anti Cancer Agents And Prodrugs Thereof |
| 02/12/2009 | US20090042819 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| 02/12/2009 | US20090042818 Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists |
| 02/12/2009 | US20090042817 Use of an Active Ingredient Combination That Contains Hydroxystilbene for Preventing and/or Treating Diseases |
| 02/12/2009 | US20090042816 Synthetic Ligands For The Differentiation Of Closely Related Toxins And Pathogens |
| 02/12/2009 | US20090042815 Macrolide Synthesis Process and Solid-State Forms |
| 02/12/2009 | US20090042814 Treatment and Diagnosis of Obligate Intracellular Pathogens |
| 02/12/2009 | US20090042813 Hoodia extract oil compositions comprising medium chain triglycerides |
| 02/12/2009 | US20090042812 Lipase inhibitors |
| 02/12/2009 | US20090042811 Synthesis of Glycerolipid Carbamates and Dicarbamates and Their Use as an Antitumor Compounds |
| 02/12/2009 | US20090042810 AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics |
| 02/12/2009 | US20090042806 Transglutaminase inhibitors and methods of use thereof |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042793 Novel Antiviral Therapies |
| 02/12/2009 | US20090042789 Method for Improving Symptom of Mood Disorder |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042781 Methods for Treating Diabetes |
| 02/12/2009 | US20090042777 G-CSF Transferrin Fusion Proteins |
| 02/12/2009 | US20090042773 P13 kinase gamma inhibitors for the treatment of anaemia |
| 02/12/2009 | US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 02/12/2009 | US20090042771 Dietary lipids for improving skin and coat of pets |
| 02/12/2009 | US20090042770 Branched Chain Amino Acid Chelate |
| 02/12/2009 | US20090042768 Purine derivatives and their use for treatment of autoimmune diseases |
| 02/12/2009 | US20090042294 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041923 Medical device having a lubricious coating with a hydrophilic compound in an interlocking network |
| 02/12/2009 | US20090041877 Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 02/12/2009 | US20090041874 Karaya Gum-Based Hydrophilic Gel System for Skin Care |
| 02/12/2009 | US20090041866 Abnormal protein removing composition |
| 02/12/2009 | US20090041865 Extract of the Family Dioscoreaceae and Composition for Preventing or Treating Peripheral Neuropathy Comprising the Same |
| 02/12/2009 | US20090041863 Use of GSK3 inhibitors in combination with radiation therapies |
| 02/12/2009 | US20090041861 Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture |
| 02/12/2009 | US20090041857 Analgesic Cream |
| 02/12/2009 | US20090041856 Methods for promoting hair growth |
| 02/12/2009 | US20090041850 Process for preparation of swellable and degradable microspheres |
| 02/12/2009 | US20090041849 Dissolution aids for oral peptide delivery comprising a biguanide |
| 02/12/2009 | US20090041846 Minocycline oral dosage forms for the treatment of acne |
| 02/12/2009 | US20090041845 Implantable medical devices having thin absorbable coatings |
| 02/12/2009 | US20090041844 Modified Release Formulation |
| 02/12/2009 | US20090041843 Pharmaceutical preparation having excellent photostability |
| 02/12/2009 | US20090041841 Controlled release tablet formulations for the prevention of arrhythmias |
| 02/12/2009 | US20090041840 Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration |
| 02/12/2009 | US20090041839 Pharmaceutical compositions for the treatment of pain |
| 02/12/2009 | US20090041835 Method of inhibiting leakage of drug encapsulated in liposomes |
| 02/12/2009 | US20090041834 Compositions and methods for treating lymphoma |
| 02/12/2009 | US20090041832 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 02/12/2009 | US20090041831 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 02/12/2009 | US20090041820 Functional polymer compositions |
| 02/12/2009 | US20090041814 Cosmetic composition |
| 02/12/2009 | US20090041809 Double-stranded locked nucleic acid compositions |
| 02/12/2009 | US20090041808 Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction |
| 02/12/2009 | US20090041806 Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity |
| 02/12/2009 | US20090041800 Methods for Treating Dependence |
| 02/12/2009 | US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |